ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,339Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 331

$506K Total Retail Price of All Prescriptions

Rank: 19 out of 331

495 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 11,226 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$31 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
RANITIDINE HCL 1,015 658 1 4
SIMVASTATIN 923 726 2 1
ENALAPRIL MALEATE 646 505 3 3
TRAMADOL HCL 552 287 4 23
METFORMIN HCL 549 385 5 2
SYNTHROID 516 338 6 11
AMLODIPINE BESYLATE 477 368 7 6
OMEPRAZOLE 411 256 8 5
GABAPENTIN 387 211 9 7
LEVOTHYROXINE SODIUM 305 246 10 9
GLIPIZIDE 303 251 11 19
LISINOPRIL 296 205 12 13
INSULIN SYRINGE 292 235 13 37
METOPROLOL TARTRATE 286 234 14 16
NAPROXEN 281 155 15 59
GLYBURIDE MICRONIZED 276 137 R 16 67
PENTOXIFYLLINE 226 151 17 53
HYDROCHLOROTHIAZIDE 221 106 18 10
LOSARTAN POTASSIUM 221 143 18 8
HUMULIN 70-30 219 186 20 45
FUROSEMIDE 206 167 21 15
LOSARTAN-HYDROCHLOROTHIAZIDE 198 166 22 14
ALENDRONATE SODIUM 186 144 23 17
ATENOLOL 186 133 23 12
BACLOFEN 175 70 25 99
PLAVIX 173 144 26 46
CLOPIDOGREL 162 130 27 39
HUMULIN N 156 129 28 44
DOXAZOSIN MESYLATE 154 120 29 30
IBUPROFEN 142 69 30 81
ISOSORBIDE MONONITRATE ER 142 110 30 31
SINGULAIR 136 82 32 58
NABUMETONE 135 84 33 25
DONEPEZIL HCL 131 131 34 38
VERAPAMIL ER 119 76 35 35
ZOLPIDEM TARTRATE 116 96 36 22
CARVEDILOL 113 81 37 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 84 38 79
METOCLOPRAMIDE HCL 107 85 39 109
VERAPAMIL HCL 101 80 40 190
MECLIZINE HCL 99 77 41 51
SURE COMFORT 92 73 42 57
GEMFIBROZIL 91 58 43 65
FINASTERIDE 82 59 44 74
ISOSORBIDE DINITRATE 81 63 45 91
COUMADIN 80 57 46 149
PANTOPRAZOLE SODIUM 76 50 47 41
DIGOXIN 76 76 47 64
NAMENDA 75 75 49 63
KETOCONAZOLE 73 36 50 96
SERTRALINE HCL 67 54 51 28
VENTOLIN HFA 61 27 52 179
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 50 53 107
AMOX TR-POTASSIUM CLAVULANATE 59 33 53 114
ORPHENADRINE CITRATE 57 0 R 55 122
CEPHALEXIN 53 39 56 133
PROAIR HFA 52 16 57 83
ADVAIR DISKUS 52 40 57 92
BETAMETHASONE DIPROPIONATE 50 33 59 100
IRBESARTAN 50 40 59 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.